Article
Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Oncogene - 14 Nov 2005
Astrinidis Aristotelis, Henske Elizabeth P
Abstract excerpt
The most exciting advances in the tuberous sclerosis complex (TSC) field occurred in 1993 and 1997 with the cloning of the TSC2 and TSC1 genes, respectively, and in 2003 with the identification of Rheb as the target of tuberin's (TSC2) GTPase activating protein (GAP) domain. Rheb has a dual role: it activates mTOR and inactivates B-Raf. Activation of mTOR leads to increased protein synthesis through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
